Long-term Safety and Effectiveness of Growtropin®-II Treatment in Children With Short Stature

Treatment Of Children With Short Stature At An Age Of 3-7 Years Who Were Born Small For Gestational Age

NCT00174408 ·Status: COMPLETED ·Phase: PHASE3

Treatment With Recombinant Human Growth Hormone (GH) in Children With Short Stature Secondary to a Long Term Corticoid Therapy

NCT00174187 ·Status: TERMINATED ·Phase: PHASE3

Growth Response in Short Children Suffering From a Disease With Growth Retardation and Treated With Somatropin

NCT00488124 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of Growth Hormone Treatment in Children Small for Gestational Age

NCT00557336 ·Status: COMPLETED ·Phase: PHASE3

Somatropin Therapy In Children Born Preterm But Appropriate For Gestational Age

NCT00174460 ·Status: COMPLETED ·Phase: PHASE2

Treatment With Recombinant Human Growth Hormone Genotonorm (Registered) In Children With Short Stature Secondary

NCT00174278 ·Status: COMPLETED ·Phase: PHASE3

The Effect of Growth Hormone in Very Young Girls With Turner Syndrome

NCT00406926 ·Status: COMPLETED ·Phase: PHASE3

Non-interventional Study of Patients Using Norditropin® for Growth Hormone Deficiency or Turner Syndrome

NCT01604161 ·Status: COMPLETED

Growth Retardation In Children With Special Pathological Conditions Or Disease

NCT00163215 ·Status: COMPLETED ·Phase: PHASE3

Growth Hormone Treatment for the Prevention of Short Stature in Young Girls With Turner Syndrome Before the Age of 4 Years

NCT01066052 ·Status: COMPLETED ·Phase: PHASE4

Long-Term Growth and Skeletal Effects of Early Growth Hormone Treatment in Turner Syndrome

NCT00266656 ·Status: COMPLETED ·Phase: PHASE4

Efficacy and Safety of DA-3002 in Children With Idiopathic Short Stature

NCT01786902 ·Status: COMPLETED ·Phase: PHASE3

Safety and Efficacy of Somatropin in Children With Growth Hormone Deficiency

NCT01502124 ·Status: COMPLETED ·Phase: PHASE3

A 4 Year Combination Therapy of Growth Hormone and (GnRH) Agonist in Children With a Short Predicted Height

NCT00840944 ·Status: UNKNOWN ·Phase: PHASE4

A Study Extension Period of PEG-somatropin (Pegylated-somatropin) in the Treatment of Children With Idiopathic Short Stature

NCT03255694 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Efficacy and Safety Study of Sr-hGH in Comparison With Daily hGH in ISS Patients

NCT02042170 ·Status: COMPLETED ·Phase: PHASE2

A Study of the Genetic Basis of Response to Growth Hormone Treatment in Children With Idiopathic Short Stature

NCT05894876 ·Status: TERMINATED

Evolution Of Growth Rate In Children With Growth Retardation Due to Glucocorticosteroid Therapy And Treated By Genotonorm

NCT00163189 ·Status: COMPLETED ·Phase: PHASE3

Drug Use Investigation of Somatropin for GHD-ADULTS.

NCT00601419 ·Status: COMPLETED

Use of Somatropin in Turner Syndrome

NCT01518036 ·Status: COMPLETED ·Phase: PHASE3

A Study of PEG-somatropin Injection to Treat Children of Turner Syndrome

NCT03189160 ·Status: UNKNOWN ·Phase: PHASE2

Investigating Efficacy and Safety of Once-weekly NNC0195-0092 Treatment Compared to Daily Growth Hormone Treatment (Norditropin® FlexPro®) in Growth Hormone Treatment naïve Pre-pubertal Children With Growth Hormone Deficiency

NCT02616562 ·Status: COMPLETED ·Phase: PHASE2

Long Term Effect of Somatropin in Subjects With Intrauterine Growth Retardation

NCT01734447 ·Status: COMPLETED ·Phase: PHASE4

Comparison of Weekly Somatrogon to Daily Genotropin in Children Born Small for Gestational Age or With Idiopathic Short Stature.

NCT07226089 ·Status: RECRUITING ·Phase: PHASE3

Observational Study of the Safety and Efficacy of Norditropin® in Patients With SGA (Small for Gestational Age) Short Stature That Are Still Growing

NCT01110928 ·Status: COMPLETED